FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY

被引:1886
作者
HENNEKENS, CH
机构
[1] HARVARD UNIV, SCH MED, CHANNING LAB, DEPT MED, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, CHANNING LAB, DEPT PREVENT MED, BOSTON, MA 02115 USA
[3] BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA
关键词
D O I
10.1056/nejm198907203210301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:129 / 135
页数:7
相关论文
共 21 条
[11]  
Hennekens CH., 1987, EPIDEMIOLOGY MED
[12]   REGULAR ASPIRIN USE AND MYOCARDIAL-INFARCTION [J].
JICK, H ;
MIETTINEN, OS .
BRITISH MEDICAL JOURNAL, 1976, 1 (6017) :1057-1059
[13]  
KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P336
[14]   ARACHIDONIC-ACID METABOLITES AND THE INTERACTIONS BETWEEN PLATELETS AND BLOOD-VESSEL WALLS [J].
MONCADA, S ;
VANE, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (20) :1142-1147
[15]   CLINICAL-PHARMACOLOGY OF PLATELET CYCLOOXYGENASE INHIBITION [J].
PATRONO, C ;
CIABATTONI, G ;
PATRIGNANI, P ;
PUGLIESE, F ;
FILABOZZI, P ;
CATELLA, F ;
DAVI, G ;
FORNI, L .
CIRCULATION, 1985, 72 (06) :1177-1184
[16]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612
[17]   RANDOMIZED TRIAL OF PROPHYLACTIC DAILY ASPIRIN IN BRITISH MALE DOCTORS [J].
PETO, R ;
GRAY, R ;
COLLINS, R ;
WHEATLEY, K ;
HENNEKENS, C ;
JAMROZIK, K ;
WARLOW, C ;
HAFNER, B ;
THOMPSON, E ;
NORTON, S ;
GILLILAND, J ;
DOLL, R .
BRITISH MEDICAL JOURNAL, 1988, 296 (6618) :313-316
[18]  
SCHOENBERGER JA, 1980, JAMA-J AM MED ASSOC, V243, P661
[19]   THE 2 X 2 FACTORIAL DESIGN - ITS APPLICATION TO A RANDOMIZED TRIAL OF ASPIRIN AND CAROTENE IN UNITED-STATES PHYSICIANS [J].
STAMPFER, MJ ;
BURING, JE ;
WILLETT, W ;
ROSNER, B ;
EBERLEIN, K ;
HENNEKENS, CH .
STATISTICS IN MEDICINE, 1985, 4 (02) :111-116
[20]   EFFECT OF ALTERNATE-DAY REGULAR AND ENTERIC-COATED ASPIRIN ON PLATELET-AGGREGATION, BLEEDING-TIME, AND THROMBOXANE-A2 LEVELS IN BLEEDING-TIME BLOOD [J].
STAMPFER, MJ ;
JAKUBOWSKI, JA ;
DEYKIN, D ;
SCHAFER, AI ;
WILLETT, WC ;
HENNEKENS, CH .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03) :400-404